Tech Company Financing Transactions
Poniard Pharmaceuticals Funding Round
On 3/16/2010, Poniard Pharmaceuticals raised $6.3 million in investment from private investors.
Transaction Overview
Company Name
Announced On
3/16/2010
Transaction Type
Venture Equity
Amount
$6,300,000
Round
Undisclosed
Investors
Proceeds Purpose
The firm said the funding will go to fund continued development of its treatments for small cell lung cancer.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
300 Elliott Ave. West 530
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Mike Perry
Browse more venture capital transactions:
Prev: 3/16/2010: BrightEdge venture capital transaction
Next: 3/17/2010: Cadre Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs